The clinical effect of clomipramine in chronic idiopathic pain disorder revisited using the Spielberger State Anxiety Symptom Scale (SSASS) as outcome scale
- 31 December 2009
- journal article
- research article
- Published by Elsevier BV in Journal of Affective Disorders
- Vol. 119 (1-3), 43-51
- https://doi.org/10.1016/j.jad.2009.03.007
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Dose-response Relationship of Pregabalin in Patients with Generalized Anxiety Disorder. A Pooled Analysis of Four Placebo-controlled TrialsPharmacopsychiatry, 2007
- Psychiatric outcome studies (POS): Does treatment help the patients? A Popperian approach to research in clinical psychiatryNordic Journal of Psychiatry, 2007
- A randomized, double-blind, placebo-controlled trial of duloxetine in the treatment of women with fibromyalgia with or without major depressive disorderPain, 2005
- A double‐blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorderArthritis & Rheumatism, 2004
- The Bech–Rafaelsen Melancholia Scale (MES) in clinical trials of therapies in depressive disorders: a 20‐year review of its use as outcome measureActa Psychiatrica Scandinavica, 2002
- Treatment outcome of chronic non-malignant pain patients managed in a Danish multidisciplinary pain centre compared to general practice: a randomised controlled trialPain, 2000
- The Withdrawal Syndrome Scale for Alcohol and Related Psychoactive Drugs Inter-Observer Reliability and Construct ValidityNordisk Psykiatrisk Tidsskrift, 1989
- Personality in depression: concordance between clinical assessment and questionnairesActa Psychiatrica Scandinavica, 1986
- The Diagnosis of Depressive Syndromes and the Prediction of E.C.T. ResponseThe British Journal of Psychiatry, 1965
- An Inventory for Measuring DepressionArchives of General Psychiatry, 1961